AAAAAA

   
Results: 1-22 |
Results: 22
Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults
Authors: McMahon, D Lederman, M Haas, DW Haubrich, R Stanford, J Cooney, E Horton, J Kelleher, D Ross, L Cutrell, A Lee, D Spreen, W Mellors, JW
Citation: D. Mcmahon et al., Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults, ANTIVIR TH, 6(2), 2001, pp. 105-114
Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression
Authors: Gange, SJ Mellors, JW Lau, B Detels, R Phair, JP Munoz, A Margolick, JB
Citation: Sj. Gange et al., Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression, AIDS RES H, 17(13), 2001, pp. 1223-1229
Immunologic and virologic response to highly active antiretroviral therapyin the Multicenter AIDS Cohort Study
Authors: Yamashita, TE Phair, JP Munoz, A Margolick, JB Detels, R O'Brien, SJ Mellors, JW Wolinsky, SM Jacobson, LP
Citation: Te. Yamashita et al., Immunologic and virologic response to highly active antiretroviral therapyin the Multicenter AIDS Cohort Study, AIDS, 15(6), 2001, pp. 735-746
Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance
Authors: Hammond, JL Koontz, DL Bazmi, HZ Beadle, JR Hostetler, SE Kini, GD Aldern, KA Richman, DD Hostetler, KY Mellors, JW
Citation: Jl. Hammond et al., Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance, ANTIM AG CH, 45(6), 2001, pp. 1621-1628
Antiretroviral therapy for previously treated patients.
Authors: Montaner, JSG Mellors, JW
Citation: Jsg. Montaner et Jw. Mellors, Antiretroviral therapy for previously treated patients., N ENG J MED, 345(6), 2001, pp. 452-455
Restoration of anti-human immunodeficiency virus type 1 (HIV-1) responses in CD8(+) T cells from late-stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein-loaded dendritic cells
Authors: Fan, Z Huang, XL Borowski, L Mellors, JW Rinaldo, CR
Citation: Z. Fan et al., Restoration of anti-human immunodeficiency virus type 1 (HIV-1) responses in CD8(+) T cells from late-stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein-loaded dendritic cells, J VIROLOGY, 75(9), 2001, pp. 4413-4419
CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects
Authors: Huang, XL Fan, Z Kalinyak, C Mellors, JW Rinaldo, CR
Citation: Xl. Huang et al., CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects, CL DIAG LAB, 7(2), 2000, pp. 279-287
In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine
Authors: Hostetler, KY Hammond, JL Kini, GD Hostetler, SE Beadle, JR Aldern, KA Chou, TC Richman, DD Mellors, JW
Citation: Ky. Hostetler et al., In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine, ANTIVIR CHE, 11(3), 2000, pp. 213-219
Natural history of HIV-1 infection
Authors: Vergis, EN Mellors, JW
Citation: En. Vergis et Jw. Mellors, Natural history of HIV-1 infection, INF DIS CL, 14(4), 2000, pp. 809
Antiretroviral drug resistance testing in adult HIV-1 infection - Recommendations of an International AIDS Society-USA panel
Authors: Hirsch, MS Brun-Vezinet, F D'Aquila, RT Hammer, SM Johnson, VA Kuritzkes, DR Loveday, C Mellors, JW Clotet, B Conway, B Demeter, LM Vella, S Jacobsen, DM Richman, DD
Citation: Ms. Hirsch et al., Antiretroviral drug resistance testing in adult HIV-1 infection - Recommendations of an International AIDS Society-USA panel, J AM MED A, 283(18), 2000, pp. 2417-2426
In vitro selection of mutations in the human immunodeficiency virus type 1reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3 '-azido-3 '-deoxythymidine
Authors: Bazmi, HZ Hammond, JL Cavalcanti, SCH Chu, CK Schinazi, RF Mellors, JW
Citation: Hz. Bazmi et al., In vitro selection of mutations in the human immunodeficiency virus type 1reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3 '-azido-3 '-deoxythymidine, ANTIM AG CH, 44(7), 2000, pp. 1783-1788
Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency
Authors: Rinaldo, CR Huang, XL Fan, Z Margolick, JB Borowski, L Hoji, A Kalinyak, C McMahon, DK Riddler, SA Hildebrand, WH Day, RB Mellors, JW
Citation: Cr. Rinaldo et al., Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency, J VIROLOGY, 74(9), 2000, pp. 4127-4138
Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men
Authors: Lyles, RH Munoz, A Yamashita, TE Bazmi, H Detels, R Rinaldo, CR Margolick, JB Phair, JP Mellors, JW
Citation: Rh. Lyles et al., Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men, J INFEC DIS, 181(3), 2000, pp. 872-880
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine
Authors: Gulick, RM Mellors, JW Havlir, D Eron, JJ Meibohm, A Condra, JH Valentine, FT McMahon, D Gonzalez, C Jonas, L Emini, EA Chodakewitz, JA Isaacs, R Richman, DD
Citation: Rm. Gulick et al., 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine, ANN INT MED, 133(1), 2000, pp. 35-39
Virologic, immunologic, and immune activation markers as predictors of HIV-associated weight loss prior to AIDS
Authors: Lyles, RH Tang, AM Smit, E Mellors, JW Margolick, JB Visscher, BR Phair, JP Graham, NMH
Citation: Rh. Lyles et al., Virologic, immunologic, and immune activation markers as predictors of HIV-associated weight loss prior to AIDS, J ACQ IMM D, 22(4), 1999, pp. 386-394
Effective salvage therapy for HIV-1 infection - an unmet challenge
Authors: Montaner, JSG Mellors, JW
Citation: Jsg. Montaner et Jw. Mellors, Effective salvage therapy for HIV-1 infection - an unmet challenge, ANTIVIR TH, 4(2), 1999, pp. 59-60
Stavudine resistance: an update on susceptibility following prolonged therapy
Authors: Lin, PF Gonzalez, CJ Griffith, B Friedland, G Calvez, V Ferchal, F Schinazi, RF Shepp, DH Ashraf, AB Wainberg, MA Soriano, V Mellors, JW Colonno, RJ
Citation: Pf. Lin et al., Stavudine resistance: an update on susceptibility following prolonged therapy, ANTIVIR TH, 4(1), 1999, pp. 21-28
Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex
Authors: Lyles, RH Chu, C Mellors, JW Margolick, JB Detels, R Giorgi, JV Al-Shboul, Q Phair, JP
Citation: Rh. Lyles et al., Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex, AIDS, 13(3), 1999, pp. 341-349
Adefovir for the treatment of HIV infection - If not now, when?
Authors: Mellors, JW
Citation: Jw. Mellors, Adefovir for the treatment of HIV infection - If not now, when?, J AM MED A, 282(24), 1999, pp. 2355-2356
Effects of anticoagulant, processing delay, and assay method (branched DNAversus reverse transcriptase PCR) on measurement of human immunodeficiencyvirus type 1 RNA levels in plasma
Authors: Kirstein, LM Mellors, JW Rinaldo, CR Margolick, JB Giorci, JV Phair, JP Dietz, E Gupta, P Sherlock, CH Hogg, R Montaner, JSG Munoz, A
Citation: Lm. Kirstein et al., Effects of anticoagulant, processing delay, and assay method (branched DNAversus reverse transcriptase PCR) on measurement of human immunodeficiencyvirus type 1 RNA levels in plasma, J CLIN MICR, 37(8), 1999, pp. 2428-2433
Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens
Authors: Rinaldo, CR Liebmann, JM Huang, XL Fan, Z Al-Shboul, Q McMahon, DK Day, RD Riddler, SA Mellors, JW
Citation: Cr. Rinaldo et al., Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens, J INFEC DIS, 179(2), 1999, pp. 329-336
Biochemical characterization of HIV-1 reverse transcriptases encoding mutations at amino acid residues 161 and 208 involved in resistance to phosphonoformate
Authors: Tramontano, E Piras, G Mellors, JW Putzolu, M Bazmi, HZ La Colla, P
Citation: E. Tramontano et al., Biochemical characterization of HIV-1 reverse transcriptases encoding mutations at amino acid residues 161 and 208 involved in resistance to phosphonoformate, BIOCH PHARM, 56(12), 1998, pp. 1583-1589
Risultati: 1-22 |